Serotonin reuptake inhibition does not enhance short term modulation of the exercise ventilatory response

Respiration Physiology

Volumn 121, Issue 1, 2000, Pages 45-52

  Henderson, D R ^a   Konkle, D M ^a   Mitchell, G S ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

5 HT; Dead space; Exercise; Fenfluramine; Fluoxetine; Goat; Mammals; Mediators; Pharmacological agents; Serotonin; Upper airways; Ventilatory response

Indexed keywords

FENFLURAMINE; FLUOXETINE; SEROTONIN; SEROTONIN RECEPTOR; SEROTONIN UPTAKE INHIBITOR;

AMINO ACID TRANSPORT; ANIMAL EXPERIMENT; ARTICLE; BLOOD GAS ANALYSIS; CONTROLLED STUDY; EXERCISE; FEMALE; GOAT; LUNG DEAD SPACE; LUNG VENTILATION; NONHUMAN; PRIORITY JOURNAL; SEROTONIN RELEASE;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; EXERTION; FEMALE; FENFLURAMINE; FLUOXETINE; GOATS; RESPIRATORY DEAD SPACE; RESPIRATORY MECHANICS; SEROTONIN; SEROTONIN UPTAKE INHIBITORS;

EID: 0034036896     PISSN: 00345687     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0034-5687(00)00112-2     Document Type: Article

References (26)

1. Artigas F. 5-HT and antidepressants: new views from microdialysis studies. Trends Pharmacol. Sci. 14:1993;262.
2. Artigas F., Romero L., de Montigny C., Blier P. Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists. Trends Neurosci. 19:1996;378-383.
3. Bach K.B., Lutcavage M.E., Mitchell G.S. Serotonin is necessary for short term modulation of the exercise ventilatory response. Respir. Physiol. 91:1993;57-70.
4. Barondes S.H. Thinking about prozac. Science. 263:1994;1102-1103.
5. Beasley C.M., Masica D.N., Potvin J.H. Fluoxetine: a review of receptor and functional effects and their clinical implications. Psychopharmacology. 107:1992;1-10.
6. Bel N., Artigas F. Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei. Synapse. 15:1993;243-245.
7. Blier P., de Montigny C., Chaput Y. Modifications of the serotonin system by antidepressant treatments: implications for the therapeutic response in major depression. J. Clin. Psychopharmacol. 7(Suppl.):1987;24-35.
8. Blier P., de Montigny C. Current advances and trends in the treatment of depression. Trends Pharmacol. Sci. 15:1994;220-226.
9. Bonanno G., Fassio A., Ruelle A., Raiteri M. Fenfluramine releases serotonin from human brain nerve endings by a dual mechanism. J. Neurochem. 63:1994;1163-1166.
10. Dempsey J.A., Forester H.V., Ainsworth D.M. Regulation of hyperpnea, hyperventilation and respiratory muscle recruitment during exercise. Dempsey J.A., Pack A.I. Regulation of Breathing. 1995;1065-1117 Marcel Dekker, New York.
11. Fuller R.W. Microdialysis studies with 5-HT reuptake inhibitors. Trends Neurosci. 14:1993;397-398.
12. Gobbi M., Fritolli E., Mennini T., Garattini S. Releasing activities of d-fenfluramine and fluoxetine on rat hippocampal synaptosomes preloaded with [3H]serotonin. Naunyn Schmiedebergs Arch. Pharmacol. 345:1992;1-6.
13. Henderson D.R., Konkle D.M., Mitchell G.S. Effects of serotonin re-uptake inhibition on ventilatory control in goats. Respir. Physiol. 115:1999;1-10.
14. Jacobs B.L., Azmitia E.C. Structure and function of the brain serotonin system. Physiol. Rev. 75:1992;165-229.
15. Kalia M. Reversible, short-lasting, and dose-dependent effect of (+)-fenfluramine on neocortical serotonergic axons. Brain Res. 548:1991;111-125.
16. Maj J., Moryl E. Effects of fluoxetine given chronically on the responsiveness of 5-HT receptor subpopulations to their agonists. Eur. Neuropsychopharmacol. 3:1993;85-94.
17. McCrimmon D.R., Dekin M.S., Mitchell G.S. Glutamate, GABA, and serotonin in ventilatory control. Dempsey J.A., Pack A.I. Regulation of Breathing. 1995;151-218 Marcel Dekker, New York.
18. Mitchell G.S. Ventilatory control during exercise with increased respiratory dead space in goats. J. Appl. Physiol. 69:1990;718-727.
19. Mitchell G.S., Bach K.B., Martin P.A., Foley K.T. Modulation and plasticity of the exercise ventilatory response. Funkt. Biol. Syst. 23:1993;269-277.
20. Mitchell G.S., Turner D.L., Foley K.T., Bach K.B. Spinal serotonin receptors are necessary for short term modulation (STM) of the exercise ventilatory response in goats. FASEB J. 2:1995;A666.
21. Ni Y.G., Miledi R. Blockade of 5-HT2C receptors by fluoxetine (Prozac). Proc. Natl. Acad. Sci. USA. 94:1997;2036-2040.
22. Pineyro G., Blier P., Dennis T., de Montigny C. Desensitization of the neuronal 5-HT carrier following its long-term blockade. J. Neurosci. 14:1994;3036-3047.
23. Rowland N.E., Carlton J. Neurobiology of an anorectic drug: fenfluramine. Prog. Neurobiol. 27:1986;13-62.
24. Rutter J.J., Gundlah C., Auerbach S.B. Increase in extracellular serotonin produced by uptake inhibitors is enhanced after chronic treatment with fluoxetine. Neurosci. Lett. 171:1994;183-186.
25. Stanford S.C. Prozac: panacea of puzzle? Trends Pharmacol. Sci. 17:1997;150-154.
26. Wong D.T., Bymaster F.P., Engleman E.A. Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication. Life Sci. 57:1995;411-441.